Properties
What is it?
Nucef Composition: Ceftriaxone 1.0 g Active substance: Ceftriaxone sodium tris(sesquihydrate) 1.193 g (calculated as ceftriaxone) 1.0 g Indications for use: Infectious-inflammatory diseases caused by microorganisms sensitive to ceftriaxone: infections of the abdominal organs, including peritonitis, inflammatory diseases of the gastrointestinal tract, biliary tract (including cholangitis, gallbladder empyema), upper and lower respiratory tract and ENT organs infections (including acute and complicated chronic bronchitis, pneumonia, lung abscess, pleural empyema), epiglottitis, bone and joint, skin and soft tissue infections, genitourinary system infections (including pyelitis, acute and chronic pyelonephritis, cystitis, prostatitis, epididymitis), infected wounds and burns, gonorrhea without complications, including those caused by penicillinase-producing microorganisms, sepsis and bacterial septicemia, bacterial meningitis and endocarditis, Lyme disease (tick-borne borreliosis), infections in immunocompromised patients, prophylaxis and treatment of postoperative infectious complications. Contraindications: Hypersensitivity to ceftriaxone and other cephalosporins, penicillins, carbapenems; first trimester of pregnancy, lactation period; hyperbilirubinemia in newborns and premature infants; administration with intravenous calcium-containing solutions in newborns. Use during pregnancy and lactation: The drug can be used during pregnancy (II and III trimesters) only if the expected benefit to the mother outweighs the potential risk to the fetus (ceftriaxone crosses the placental barrier). If the drug needs to be used during lactation, breastfeeding should be discontinued (excreted in breast milk). Storage conditions: Store in a place protected from light at a temperature not exceeding 25 C. Keep out of reach of children.